Brief: iCAD, CancerIQ Partner to Integrate AI-Enabled Technology With Risk Assessment and Care Management Platform
20/11/2023 13:20
Nov 20 (Reuters) - ICAD Inc ICAD.O :
* ICAD AND CANCERIQ ANNOUNCE PARTNERSHIP TO INTEGRATE
AI-ENABLED
TECHNOLOGY WITH BEST-IN-CLASS RISK ASSESSMENT AND CARE
MANAGEMENT PLATFORM OFFERING A COMPREHENSIVE BREAST HEALTH CARE
SOLUTION
Source text for Eikon: ID:nGNX1wTqMG
Further company coverage: ICAD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on icad
See all newsIcad Inc Reports Results For The Quarter Ended March 31: Earnings Summary
Brief: iCAD, Inc. Q1 Gross Profit USD 4.2 Million
Icad Inc Expected To Post A Loss Of 6 Cents A Share: Earnings Preview
U.S. RESEARCH ROUNDUP- Cognex, Equifax, Netflix
RadNet falls after $103 million all-stock acquisition to buy iCAD